Balchem
BCPC
166.41
+1.12
+0.68%
Balchem
US · BCPC
#2068 by market cap
Listed 1970
166.41
+1.12
+0.68%
Live - 5344 symbols - heartbeat 398s ago
· 2026-10-07 19:54
After-hours
166.41
0.00%
- Market cap
- 5.30B
- P/E (TTM)i
- 32.76
- P/Bi
- 4.07
- EPSi
- 4.75
- Div yieldi
- 0.58%
- 52W posi
- 60%
Reader sentiment
Are you bullish or bearish on BCPC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.1 percentage points.
Institutional ownership
- Held by institutions
- 92.19% +0.13pp
- Institutions
- 491 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund79.06%
Hedge Fund6.35%
Public Company2.05%
Government Pension Fund1.53%
Sovereign Wealth Fund1.34%
Private Company0.75%
Insurance Company0.73%
Individual/Insider0.57%
Family Office/Trust0.20%
Other7.42%
Top holders as of 2026-06-30
BlackRock
15.57% · 4.96M sh
Vanguard Portfolio Management, LLC
6.97% · 2.22M sh
Vanguard Capital Management, LLC
5.25% · 1.68M sh
State Street Global Advisors
4.02% · 1.28M sh
Geode Capital Management, LLC
3.52% · 1.12M sh
Conestoga Capital Advisors, LLC
3.41% · 1.09M sh
Wasatch Advisors LP
3.30% · 1.05M sh
Nationwide Fund Advisors
2.08% · 664.59K sh
Eaton Vance Management
1.97% · 627.49K sh
First Trust Advisors L.P.
1.94% · 617.23K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 27 buys · 21 sells
| Name | Role | Stake |
|---|---|---|
| Theodore Harris | Chairperson & CEO | 0.23% |
| Carl Bengtsson | Chief Financial Officer | 0.07% |
| Job Van Gunsteren | -- | 0.03% |
| M. Tignor | Chief Human Resources Officer | 0.03% |
| Martin Reid | Senior VP & Chief Supply Chain Officer | 0.03% |
| David Fischer | Independent Director | 0.02% |
| William Backus | VP & CAO | 0.02% |
| Matthew Wineinger | Lead Independent Director | 0.02% |
| Michael Sestrick | Chief Technology Officer | 0.02% |
| Daniel Knutson | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-03-31 | Erin Gilson | Vice President | Initial Statement of Beneficial | 0 | -- |
| 2026-02-11 | Theodore Harris | Chairperson & CEO | Sale to Issuer | -10,202 | $177.49–178.68 |
| 2026-02-11 | William Backus | VP & CAO | Sale to Issuer | -935 | $177.49–178.68 |
| 2026-02-11 | M. Tignor | Chief Human Resources Officer | Sale to Issuer | -1,156 | $177.49–178.68 |
| 2026-02-11 | Frederic Boned | Senior VP and GM of Human Nutrition & Health | Sale to Issuer | -1,354 | $177.49–178.68 |
| 2026-02-11 | Carl Bengtsson | Chief Financial Officer | Sale to Issuer | -2,718 | $177.49–178.68 |
| 2026-02-11 | Hatsuki Miyata | General Counsel | Sale to Issuer | -1,058 | $177.49–178.68 |
| 2026-02-11 | Job Van Gunsteren | -- | Sale to Issuer | -814 | $177.49–178.68 |
| 2026-02-11 | Martin Reid | Senior VP & Chief Supply Chain Officer | Sale to Issuer | -1,201 | $177.49–178.68 |
| 2026-02-10 | Daniel Knutson | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | Theodore Harris | Chairperson & CEO | Other Acquisition | +25,641 | -- |
| 2026-02-10 | Theodore Harris | Chairperson & CEO | Other Derivative Acquisition | +26,900 | $178.68 |
| 2026-02-10 | David Fischer | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | Matthew Wineinger | Lead Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | Olivier Rigaud | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | William Backus | VP & CAO | Other Acquisition | +2,154 | -- |
| 2026-02-10 | William Backus | VP & CAO | Other Derivative Acquisition | +1,800 | $178.68 |
| 2026-02-10 | Kathleen Fish | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | M. Tignor | Chief Human Resources Officer | Other Acquisition | +3,129 | -- |
| 2026-02-10 | M. Tignor | Chief Human Resources Officer | Other Derivative Acquisition | +4,400 | $178.68 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.